Clinical Trials Directory

Trials / Completed

CompletedNCT06354621

Impact of Vitamin D Supplementation on Fetomaternal Outcomes in LTBI Pregnant Females

Impact of Vitamin D Supplementation on Fetomaternal Outcomes in Pregnant Females With Latent Tuberculosis Infection: A Randomized Controlled Trial in Lahore-Punjab

Status
Completed
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
99 (actual)
Sponsor
University of the Punjab · Academic / Other
Sex
Female
Age
18 Years – 35 Years
Healthy volunteers
Accepted

Summary

The goal of this randomized controlled trial is to see the effect of vitamin D supplementation on fetomaternal outcomes in pregnant females with Latent Tuberculosis infection The main question\[s\] it aims to answer are: If Vitamin D supplementation has any impact on maternal outcomes. If Vitamin D supplementation has any impact on fetal outcomes.

Detailed description

This study aims to see the impact of vitamin D supplementation on fetomaternal outcomes in pregnant females with latent tuberculosis infection. A three-arm (parallel) randomized controlled trial (RCT) will be conducted in a high-burden setting. A calculated sample of 99 (33 in each group) pregnant females with LTBI will be enrolled based on predefined inclusion criteria. Vitamin D supplementation will be given as per study protocols. Group-A (No intervention), Group-B (2000IU/day), Group-C (4000IU/day). To maintain the safety measures throughout the study all the study participants will be monitored for hypervitaminosis D. Informed consent will be obtained from all participants. The study will be conducted after approval by the ethical review board(s). The final analysis will be based on the effect of vitamin D supplementation on pre-defined fetomaternal outcomes.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTVitamin-D supplementationParticipants receiving a daily dose of vitamin D supplementation

Timeline

Start date
2023-09-01
Primary completion
2024-02-28
Completion
2024-03-20
First posted
2024-04-09
Last updated
2024-04-09

Locations

1 site across 1 country: Pakistan

Source: ClinicalTrials.gov record NCT06354621. Inclusion in this directory is not an endorsement.